Table III.
Feature | Cases (n) | Lewis y antigen
|
CD147
|
||||
---|---|---|---|---|---|---|---|
Positive cases (n) | Rate (%) | P-value | Positive cases (n) | Rate (%) | P-value | ||
Pathological type | |||||||
Serous | 30 | 27 | 90.00 | >0.05 | 26 | 86.67 | >0.05 |
Mucous | 22 | 18 | 81.82 | 14 | 63.64 | ||
Endometrioid | 3 | 3 | 100.00 | 3 | 100.00 | ||
Clear cell | 5 | 5 | 100.00 | 5 | 100.00 | ||
FIGO stage | |||||||
I-II | 39 | 33 | 84.62 | >0.05 | 28 | 71.79 | <0.05a |
III-Ⅳ | 21 | 20 | 95.24 | 20 | 95.24 | ||
Differentiation level | |||||||
Well | 21 | 17 | 80.95 | >0.05 | 15 | 71.43 | >0.05 |
Moderate | 21 | 18 | 85.71 | 16 | 76.19 | ||
Poor | 18 | 18 | 100.00 | 17 | 94.44 | ||
Lymphatic metastasis | |||||||
No | 48 | 41 | 85.42 | >0.05 | 36 | 75.00 | <0.05a |
Yes | 12 | 12 | 100.00 | 12 | 100.00 |
Statistically significant differences. P-values were determined using the χ2 test. FIGO, International Federation of Gynecology and Obstetrics.